Private Asset Management Has Boosted Amgen (AMGN) Stake By $524,190; GIVAUDAN SA UNSPONSORED ADR SWITZERLAND (GVDNY) Shorts Raised By 257.5%

Givaudan SA (OTCMKTS:GVDNY) Logo

GIVAUDAN SA UNSPONSORED ADR SWITZERLAND (OTCMKTS:GVDNY) had an increase of 257.5% in short interest. GVDNY’s SI was 71,500 shares in April as released by FINRA. Its up 257.5% from 20,000 shares previously. With 75,600 avg volume, 1 days are for GIVAUDAN SA UNSPONSORED ADR SWITZERLAND (OTCMKTS:GVDNY)’s short sellers to cover GVDNY’s short positions. The SI to GIVAUDAN SA UNSPONSORED ADR SWITZERLAND’s float is 0.02%. The stock increased 0.66% or $0.3 during the last trading session, reaching $45.98. About 25,255 shares traded. Givaudan SA (OTCMKTS:GVDNY) has 0.00% since April 8, 2017 and is . It has underperformed by 11.55% the S&P500.

Private Asset Management Inc increased Amgen Inc (AMGN) stake by 390.97% reported in 2017Q4 SEC filing. Private Asset Management Inc acquired 3,030 shares as Amgen Inc (AMGN)’s stock declined 2.99%. The Private Asset Management Inc holds 3,805 shares with $662,000 value, up from 775 last quarter. Amgen Inc now has $121.16 billion valuation. The stock decreased 2.24% or $3.86 during the last trading session, reaching $168.14. About 3.75 million shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 3.78% since April 8, 2017 and is uptrending. It has underperformed by 7.77% the S&P500.

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. has $220 highest and $160 lowest target. $193.66’s average target is 15.18% above currents $168.14 stock price. Amgen Inc. had 87 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, August 23 by Oppenheimer. As per Tuesday, December 20, the company rating was downgraded by Credit Suisse. The firm has “Buy” rating by Oppenheimer given on Friday, July 21. The stock has “Buy” rating by Mizuho on Sunday, October 29. Deutsche Bank maintained it with “Buy” rating and $195 target in Friday, July 31 report. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Buy” rating by Oppenheimer on Tuesday, August 29. The rating was reinitiated by Jefferies on Tuesday, July 11 with “Buy”. Citigroup maintained Amgen Inc. (NASDAQ:AMGN) rating on Friday, July 29. Citigroup has “Neutral” rating and $175 target. The firm has “Neutral” rating by UBS given on Wednesday, July 26. The stock of Amgen Inc. (NASDAQ:AMGN) has “Hold” rating given on Wednesday, June 7 by Bernstein.

Investors sentiment increased to 1.22 in 2017 Q4. Its up 0.23, from 0.99 in 2017Q3. It improved, as 73 investors sold AMGN shares while 458 reduced holdings. 122 funds opened positions while 527 raised stakes. 551.71 million shares or 0.60% less from 555.05 million shares in 2017Q3 were reported. Signaturefd Ltd Llc has invested 0.08% in Amgen Inc. (NASDAQ:AMGN). Ballentine Prtn Ltd Liability Corporation reported 3,167 shares. Caisse De Depot Et Placement Du Quebec reported 422,233 shares. Opus Inv accumulated 35,600 shares or 1.1% of the stock. Tru Communication Of Vermont owns 37,889 shares for 0.61% of their portfolio. Wellington Mgmt Llp holds 0.26% or 6.69M shares in its portfolio. Aperio Gru Limited Com has 0.4% invested in Amgen Inc. (NASDAQ:AMGN) for 442,197 shares. Pekin Singer Strauss Asset Management Il holds 0.06% in Amgen Inc. (NASDAQ:AMGN) or 1,821 shares. Beech Hill Advsrs holds 2,003 shares or 0.17% of its portfolio. Forte Capital Limited Liability Co Adv stated it has 0.91% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Morgan Stanley accumulated 0.41% or 8.64 million shares. Utah Retirement invested 0.5% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Michigan-based Concorde Asset Mngmt Ltd Limited Liability Company has invested 0.26% in Amgen Inc. (NASDAQ:AMGN). Quantum Management stated it has 0.17% in Amgen Inc. (NASDAQ:AMGN). Fort Point Cap Partners Ltd Liability Co reported 5,504 shares.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart